Pharmaceuticals

IMS Healthcare Insight is maintaining its forecast of 4%–6% growth in pharmaceutical sales this year. Slower growth due to patent expirations and government cost mandates will be offset by growth in emerging markets. Over the next five years, patents will expire for products with sales of more than $142 billion. Drug sales are forecasted to show a 5%–8% compound annual growth rate through 2014. Sales in China are expected to increase 22%–25% annually over this period, while Brazilian sales are forecast to grow 12%–15%. Total emerging market sales are expected to grow 14%–17% to $120–$140 billion through 2014. Despite a growth rate of only 3%–6%, the US will remain the largest drug market, accounting for $390 million in sales by 2014.

Source: Reuters

< | >